State Street’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

State Street’s Portfolio TFFP Stock Details TFFP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,797	Closed	-$24.5K	–	4511
2023 Q3	$24.5K	Hold	2,797	–	–	﹤0.01%	4422
2023 Q2	$32.9K	Hold	2,797	–	–	﹤0.01%	4522
2023 Q1	$47.9K	Hold	2,797	–	–	﹤0.01%	4512
2022 Q4	$73.4K	Hold	2,797	–	–	﹤0.01%	4458
2022 Q3	$284K	Hold	2,797	–	–	﹤0.01%	3987
2022 Q2	$395K	Hold	2,797	–	–	﹤0.01%	3931
2022 Q1	$441K	Buy	2,797 +210	+8%	+$33.9K	﹤0.01%	4105
2021 Q4	$574K	Buy	2,587 +832	+47%	+$161K	﹤0.01%	3971
2021 Q3	$339K	Hold	1,755	–	–	﹤0.01%	4130
2021 Q2	$422K	Buy	+1,755	New	+$481K	﹤0.01%	3923

Other funds holding TFFP

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

State Street's TFFP Position: Q4 2023 in Review

State Street sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 2,797 shares — an estimated $24.5K sold.

State Street first reported a position in TFFP in Q2 2021 and held it in 10 quarters. The position peaked at $574K in Q4 2021. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

State Street reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
State Street sold 2,797 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $24.5K.
State Street first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
State Street's TFF Pharmaceuticals, Inc. Common Stock position peaked at $574K in Q4 2021.
23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.